Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure.
Hanon
S
S
Vijayaraman
P
P
Sonnenblick
E H
EH
Le Jemtel
T H
TH
D000804:Angiotensin II / Q000096:biosynthesis*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D002303:Cardiac Output, Low / Q000188:drug therapy* / Q000378:metabolism*; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II